President Trump Demands America-First Prescription Drug Pricing
Impact Score: 2.2
Timeline: 60 days for pharmaceutical companies to reduce drug prices
Summary: President Trump directed 17 major pharmaceutical companies to reduce U.S. drug prices to match the lowest prices in developed nations. Non-compliance threats have prompted responses from companies, including AstraZeneca and GSK. The policy could impact pharmaceutical research funding, collaborations with Vanderbilt University, and healthcare education. Opportunities exist for Vanderbilt to lead in research, policy analysis, and industry partnership adjustments.
Key Actions: VUMC to monitor pricing policy changes; Office of Federal Relations to engage policymakers; School of Medicine to research drug pricing effects and develop educational programs; Health Policy Department to lead policy discussions.
View Full Report
